Chemistry:Duvortuxizumab

From HandWiki
Short description: Monoclonal antibody
Duvortuxizumab
Monoclonal antibody
TypeSingle-chain variable fragment
SourceChimeric/Humanized hybrid (mouse/human)
TargetCD19
Clinical data
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
UNII
KEGG
Chemical and physical data
FormulaC4850H7485N1305O1487S35
Molar mass108989.98 g·mol−1

Duvortuxizumab (INN[1]) is a chimeric/humanized monoclonal antibody designed for the treatment of B-cell malignancies.[2]

This drug was developed by Janssen Global Services.[3]

References